Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iron Treatment on Vaccine Response in Kenyan Infants With Iron Deficiency
NCT06816524Recruiting
- Start
- Mar 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of Iron in iron deficiency anemia (IDA) (2 arms). Primary endpoints: NANP-specific Immunoglobulin G and Anti-measles Immunoglobulin G. Started Mar 2026; status: recruiting.
02
Drugs
Iron
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT06816524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06816524.